Christopher Riley

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

Daruka Mahadevan, Laurence Cooke, Christopher Riley et al. · Oncogene · 2007 · 277 citations

Imatinib Resistance, Chromatin, Oncology +8

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Daruka Mahadevan, Catherine Spier, Kimiko Della Croce et al. · Molecular Cancer Therapeutics · 2005 · 93 citations

MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

Wenqing Qi, Larry S. Cooke, A Stejskal et al. · BMC Cancer · 2009 · 56 citations · Full text

Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia

S. K. Jonas, Chiara Benedetto, A Flatman et al. · British Journal of Cancer · 1992 · 47 citations · Full text

Cervical Cancer, Gynecology, Pathology +6

Apoptosis Resistance in Barrett's Esophagus: Ex vivo Bioassay of Live Stressed Tissues

Kateřina Dvořáková, Claire M. Payne, Lois Ramsey et al. · The American Journal of Gastroenterology · 2005 · 45 citations